In 2013, the global OTC pharmaceuticals market is forecast to have a value of US$118.5 billion, an increase of 19.3% since 2008. Pharmacies and drugstores form a leading distribution channel in the global OTC pharmaceuticals market, accounting for 67.3% of the total value.

Despite the great promise for the consumer healthcare industry, the challenges faced by businesses and particularly the marketers, are tremendous. As more new players enter the OTC market, industry players have to contend with intensifying competition and the influx of generic products.

Brought to you by IBC Asia, the 2nd OTC Pharma Asia Summit has been researched with and developed for consumer healthcare professionals. The 2 day conference and optional workshops will provide unique insights on best practices and the latest innovations in OTC marketing, to address the major challenges. This is Asia’s ONLY event which allows attendees to explore and develop critical sales and branding strategies in line with key market trends.

Sign up for this summit today to learn about launching and marketing your OTC products successfully in this increasingly exciting region

Featuring Success Stories and Insights from Key Industry Speakers Philip Wohlsen, Asia Pacific Regional Franchise Director, OTC, Johnson and Johnson, Singapore Nils Kr Moen, Director CHC, PT Merck Tbk, Indonesia Chayanant Tiyatrakarnchai, Director– Consumer Health Care and Business Development, Sanofi A ventis, Thailand Rohit Tipnis , Regional Sales Manager, Customized Solutions, Glanbia Nutritionals, Singapore Titiek Sri Hendarti, Head of Consumer Healthcare Division, PT Combiphar, Indonesia Hemant Dande, President, Raptakos Brett & Co. Ltd, India Radhakrishna Hemmad, Regional Sales Director, Axellus A /s, Singapore Ding Ming, PhD, Head of Medical Affairs & Medical Director, China Category Team,GlaxoSmithKline Consumer Healthcare, China

PLUS Expert Views from

Veronita Rusli , Regional Director, Nicholas Hall & Company, Singapore Monica Feldman, Head of Consumer Healthcare, Euromonitor International, USA Cheah Ming Loong, General Manager - Ethical Division, Kotra Pharma, Malaysia Dr. Milind Sabnis, Principal Consultant, Frost & Sullivan, Singapore Dr. Susan Ward, Managing Director, Global Demographics Healthcare, Hong Kong

What’s new at OTC Pharma Asia 2012? IN-DEPTH FOCUS on best practices in branding, sales and marketing MORE CASR STUDEIES from established global and regional consumer health companies DETAILED ANALYSIS on Asia’s OTC markets and potential for growth NEW MARKET INSIGHTS on VMS (Vitamins, Minerals and Supplements)